Table 1.
Patients undergoing IVC filter placement | |
---|---|
N = 393 | |
N (%) or mean ± SD | |
Age (mean years ± SD) | 60.5 ± 15.5 |
Age | |
<50 years | 89 (22.6) |
50–69 years | 190 (48.3) |
≥70 years | 114 (29.0) |
Female | 194 (49.4) |
Race | |
White | 261 (66.4) |
Black | 28 (7.1) |
Latino | 15 (3.8) |
Asian-American/Pacific Islander | 49 (12.5) |
Other/unknown | 40 (10.2) |
Language | |
English | 325 (82.7) |
Spanish | 14 (3.6) |
Chinese | 14 (3.6) |
Other | 9 (2.3) |
Unknown | 31 (7.9) |
Admitting service | |
General medicine | 120 (30.5) |
Surgicala | 215 (54.7) |
Otherb | 58 (14.8) |
Type of filter placed | |
Retrievable | 280 (71.2) |
Non-retrievable or unknown filter type | 113 (28.8) |
Primary indication for filter placement | |
VTE, anticoagulation contraindicated | 294 (74.8) |
VTE, on anticoagulation or unspecified | 39 (9.9) |
High risk for VTE from surgery | 28 (7.1) |
Other | 32 (8.1) |
Comorbid medical conditions | |
History of malignancy | 203 (51.7) |
Prior VTE | 87 (22.1) |
Hypertension | 109 (27.7) |
Coronary artery disease | 41 (10.4) |
Congestive heart failure | 30 (7.6) |
Chronic lung disease | 35 (8.9) |
Length of stay (mean days ± SD) | 22.5 ± 24.7 |
Anticoagulation at dischargec | |
None | 232 (59.0) |
Warfarin only | 53 (13.5) |
Enoxaparin plus warfarin | 36 (9.2) |
Enoxaparin only | 46 (11.7) |
Disposition | |
Home | 211 (53.8) |
Skilled nursing facility/rehabilitation center | 95 (24.2) |
Other acute care facility | 32 (8.2) |
Death | 54 (13.8) |
IVC = inferior vena cava, SD = standard deviation, VTE = venous thromboembolism
aSurgical services were: general, cardiothoracic, head and neck, gynecologic, transplant, neurosurgery, orthopedics, vascular, and urology
bOther services were: cardiology, cancer service, gynecology, pediatrics, and neurology
cInformation on anticoagulation use at discharge was missing for 26 individuals